🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 76135L606 (prev. 76135L101 )
- Market Cap
- Micro Cap
- IPO
- 10/27/2020
- Previous Symbol
- PAIC (changed 1/14/2022)
- Previous Name
- Petra Acquisition, Inc
Business: Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development of innate immune system therapeutics and diagnostics for the prevention and treatment of disease. The Company has several product candidates in development.
Notes: January 24, 2025 -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, on January 28, 2025, the Company will implement a 1-for-16 reverse split of its common stock following approval at its Special Meeting of Stockholders held on January 17, 2025. The reverse stock split will be effective as of the morning of January 28, 2025, and the Company’s common stock will trade on a post-split basis at the beginning of trading on the same date under the existing trading symbol “REVB.” The CUSIP number for the common stock following the reverse stock split will be 76135L606.
Company Contact
- CEO
- James Rolke
- CFO
- Chester Zygmont, III
- Headquarters
- 4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122
- Phone
- 650-800-3717
- Investor Relations
- Sandra Vedrick · 650-800-3717 · svedrick@revbiosciences.com